Literature DB >> 19434487

A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders.

Anna J Esbensen1, Jan S Greenberg, Marsha Mailick Seltzer, Michael G Aman.   

Abstract

Medication use was examined in 286 adolescents and adults with ASD over a 4.5 year period. A total of 70% were taking a psychotropic or non-psychotropic medication at the beginning of the study. Both the number of psychotropic and non-psychotropic medications taken, and the proportion of individuals taking these medications, increased significantly over the study period, with 81% taking at least one medication 4.5 years later. Our findings suggested a high likelihood of staying medicated over time. Thus, adolescents and adults with ASD are a highly and increasingly medicated population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19434487      PMCID: PMC2829244          DOI: 10.1007/s10803-009-0750-3

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  33 in total

1.  Use of complementary and alternative medicine among children diagnosed with autism spectrum disorder.

Authors:  Ellen Hanson; Leslie A Kalish; Emily Bunce; Christine Curtis; Samuel McDaniel; Janice Ware; Judith Petry
Journal:  J Autism Dev Disord       Date:  2007-04

2.  Bidirectional effects of expressed emotion and behavior problems and symptoms in adolescents and adults with autism.

Authors:  Jan S Greenberg; Marsha Mailick Seltzer; Jinkuk Hong; Gael I Orsmond
Journal:  Am J Ment Retard       Date:  2006-07

Review 3.  Drug therapy for attention-deficit/hyperactivity disorder-like symptoms in autistic disorder.

Authors:  Philip Hazell
Journal:  J Paediatr Child Health       Date:  2007 Jan-Feb       Impact factor: 1.954

Review 4.  An update on pharmacologic treatments for autism spectrum disorders.

Authors:  Bryan H King; Jeff Q Bostic
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2006-01

5.  Psychopathology in children and adolescents with autism compared to young people with intellectual disability.

Authors:  Avril V Brereton; Bruce J Tonge; Stewart L Einfeld
Journal:  J Autism Dev Disord       Date:  2006-10

6.  Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months.

Authors: 
Journal:  Am J Psychiatry       Date:  2005-07       Impact factor: 18.112

Review 7.  Epilepsy in autism spectrum disorders.

Authors:  Roberto Canitano
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-08-24       Impact factor: 4.785

8.  Behaviour management problems as predictors of psychotropic medication and use of psychiatric services in adults with autism.

Authors:  Elias Tsakanikos; Helen Costello; Geraldine Holt; Peter Sturmey; Nick Bouras
Journal:  J Autism Dev Disord       Date:  2007-07

Review 9.  Bipolar depression: a new role for atypical antipsychotics?

Authors:  Paul E Keck
Journal:  Bipolar Disord       Date:  2005       Impact factor: 6.744

Review 10.  The use of selective serotonin reuptake inhibitors in autism and related disorders.

Authors:  David J Posey; Craig A Erickson; Kimberly A Stigler; Christopher J McDougle
Journal:  J Child Adolesc Psychopharmacol       Date:  2006 Feb-Apr       Impact factor: 2.576

View more
  60 in total

1.  Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder.

Authors:  Thomas W Frazier; Paul T Shattuck; Sarah Carter Narendorf; Benjamin P Cooper; Mary Wagner; Edward L Spitznagel
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-12-13       Impact factor: 2.576

2.  Trajectories, Long-Term Outcomes and Family Experiences of 76 Adults with Autism Spectrum Disorder.

Authors:  Brigitte Chamak; Béatrice Bonniau
Journal:  J Autism Dev Disord       Date:  2016-03

3.  Using machine learning to identify patterns of lifetime health problems in decedents with autism spectrum disorder.

Authors:  Lauren Bishop-Fitzpatrick; Arezoo Movaghar; Jan S Greenberg; David Page; Leann S DaWalt; Murray H Brilliant; Marsha R Mailick
Journal:  Autism Res       Date:  2018-05-07       Impact factor: 5.216

4.  Psychiatric comorbidity and medication use in adults with autism spectrum disorder.

Authors:  Tara R Buck; Joseph Viskochil; Megan Farley; Hilary Coon; William M McMahon; Jubel Morgan; Deborah A Bilder
Journal:  J Autism Dev Disord       Date:  2014-12

5.  Rates of Co-occurring Psychiatric Disorders in Autism Spectrum Disorder Using the Mini International Neuropsychiatric Interview.

Authors:  Maya G Mosner; Jessica L Kinard; Jasmine S Shah; Sean McWeeny; Rachel K Greene; Sarah C Lowery; Carla A Mazefsky; Gabriel S Dichter
Journal:  J Autism Dev Disord       Date:  2019-09

6.  Risk Factors for Emergency Department Utilization Among Adolescents with Autism Spectrum Disorder.

Authors:  Guodong Liu; Amanda M Pearl; Lan Kong; Sierra L Brown; Djibril Ba; Doug L Leslie; Michael J Murray
Journal:  J Autism Dev Disord       Date:  2019-11

7.  Aberrant Behaviors and Co-occurring Conditions as Predictors of Psychotropic Polypharmacy among Children with Autism Spectrum Disorders.

Authors:  Sarah L Logan; Laura Carpenter; R Scott Leslie; Elizabeth Garrett-Mayer; Kelly J Hunt; Jane Charles; Joyce S Nicholas
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-04-28       Impact factor: 2.576

8.  Is Medication Information for Children with Autism Spectrum Disorder Monitored and Coordinated Across Professionals? Findings from a Teacher Survey.

Authors:  Lynn K Koegel; Anna M Krasno; Howard Taras; Robert L Koegel; William Frea
Journal:  School Ment Health       Date:  2013-02-06

9.  Trajectories of internalizing and externalizing symptoms among adults with autism spectrum disorders.

Authors:  Ashley C Woodman; Marsha R Mailick; Jan S Greenberg
Journal:  Dev Psychopathol       Date:  2015-11-27

10.  A descriptive social and health profile of a community sample of adults and adolescents with Asperger syndrome.

Authors:  Myles Balfe; Digby Tantam
Journal:  BMC Res Notes       Date:  2010-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.